1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
FingerMotion announced a non-binding memorandum of understanding with Lyken AI Computing and BlueFlare Energy Solutions to match enterprise AI compute demand with modular behind-the-meter capacity in Western Canada, and gave an update on natural gas supply talks. The MOU does not reserve or guarantee capacity, grant exclusivity, or commit any party to financing, and no definitive gas supply agreement has been executed.
Non-binding, non-exclusive MOU dated September 3, 2026, covering Alberta, British Columbia, and Saskatchewan
FingerMotion completed acquisition of a 9.9% Lyken interest on August 17, 2026; Alset AI retains 90.1% control
FingerMotion is discussing possible firm natural gas supply with multiple suppliers, but no definitive supply agreement has been executed
The filing states no pricing, minimum capacity, revenue commitments, or development schedules have been set
Ionic Digital said the Texas grid operator ERCOT has provisionally classified the remaining 466 megawatt energization request for its Ward County campus as Base Load in its Batch Zero process. The classification is provisional and remains subject to ERCOT verification, audit and final determination under PUCT oversight, and the company continues to target energization of the final tranche by the end of 2027.
ERCOT provisionally classified the remaining 466 MW request as Base Load in the Batch Zero process.
Full energization would bring the Ward County campus to an aggregate demand of 700 MW.
The company continues to target energization of the final tranche by the end of 2027.
The classification remains provisional, subject to ERCOT's ongoing verification, audit and final classification, with PUCT oversight.
Nutex Health said an unauthorized third party has published on its website data allegedly obtained in the previously disclosed cyber security event. The company said it has not identified any material impact on its business operations or financial reporting systems so far, and that its materiality assessment is unchanged, but it cannot yet estimate the event's impact on its results or stock price.
Unauthorized party published data allegedly obtained in the cyber event on its website; the company is reviewing contents, scope and authenticity, a process expected to take several weeks
No material impact on business operations or financial reporting identified to date; materiality assessment from the August 31, 2026 Form 8-K unchanged
Several purported class action complaints filed in the U.S. District Court for the Southern District of Texas, Houston Division, after the initial August 24, 2026 disclosure
Company says it cannot predict litigation outcome or estimate impact on operations, financial condition or stock price
Circle8 Group confirmed it has submitted a preliminary, non-binding and highly indicative proposal for a possible cash offer for SThree plc, a London-listed specialist STEM business. The company says the deal is structured to be financed without issuing new Circle8 common stock, so existing shareholders would not be diluted, but it also states there is no certainty that a firm offer will be made.
Proposal is preliminary, non-binding and highly indicative; no firm offer has been made
Company says the transaction is structured to be financed without issuing additional Circle8 common stock
SThree generated approximately £1.3 billion in gross revenue in fiscal 2025; combined gross revenues could approach $3 billion
Circle8 generated more than $1.2 billion in gross revenue during 2025
Alliance Entertainment reported fiscal 2026 results for the year ended June 30, 2026, with net revenues up 8% to $1.149 billion and gross margin up 80 basis points to 13.3%. GAAP net income fell to $13.1 million, or $0.26 per diluted share, from $15.1 million, or $0.30, after a $7.8 million non-cash write-off, while adjusted diluted EPS rose 24% to $0.46 and operating cash flow was negative $1.7 million. The filing includes no financial guidance for fiscal 2027.
Net revenues rose 8% to $1.149 billion from $1.063 billion; gross profit rose 15% to $152.3 million.
GAAP net income was $13.1 million ($0.26 per diluted share) versus $15.1 million ($0.30) in fiscal 2025, including a $7.8 million non-cash write-off of a vendor rebate receivable.
Adjusted diluted EPS rose 24% to $0.46 from $0.37; adjusted EBITDA rose 14% to $41.5 million.
Net cash used in operating activities was $1.7 million, compared with $26.8 million provided in fiscal 2025; $45.7 million was available under the $120 million revolving credit facility at year-end.
KALA BIO entered into an Exclusive Distribution and Reseller Agreement with Virotek, Inc. on September 3, 2026, appointing Kala as sole distributor and reseller in the United States of a genetic testing and screening program for ophthalmology. Net profit from the program is split equally after Virotek recovers cost of goods sold, and the filing does not disclose any upfront payment or financial projections for the deal.
Agreement dated September 3, 2026 with Virotek, a Wyoming corporation; initial term of five years
Exclusivity converts to non-exclusive if Kala misses a milestone in Exhibit B by September 3, 2027, after a 30-day cure period
Net profit split equally between Virotek and Kala after cost of goods sold is recovered by Virotek
Virotek granted Kala a right of first refusal on certain dispositions of ophthalmological products, with at least 30 days to exercise
ARC Group Acquisition I Corp, a special purpose acquisition company, signed a share purchase agreement to acquire all shares of Malaysian private financing company Firstborn Top Capital Sdn. Bhd. The base consideration is $1.0 billion, adjusted for net indebtedness, working capital and transaction bonuses, and is paid in Class A shares of the SPAC, which will be renamed BlueCrest Investment, Inc. Closing requires shareholder approval and is expected in the first quarter of 2027, and existing ARCL shareholders may redeem their shares for trust funds before the vote.
Base consideration of $1.0 billion, before adjustments for closing net indebtedness, working capital and unpaid transaction bonuses
Implied pro forma enterprise value at closing of approximately $1,091.2 million, assuming $5 million of PIPE financing and 0% redemption from the $120.8 million trust account
Expected post-closing ownership: about 12.4% held by public investors and about 82.39% by existing Firstborn shareholders
Either party may terminate if closing has not occurred by January 31, 2027, subject to extension; expected closing in the first quarter of 2027
Office Properties Income Trust priced a $425 million private offering of 8.75% senior secured notes due 2031, sold to qualified institutional buyers and non-U.S. persons. The company expects to use the net proceeds, with cash on hand, to repay all outstanding borrowings under its secured revolving credit facility and secured term loan. The notes are secured by first-priority liens on 19 office properties, so shareholders should note that these assets will back the new debt.
Priced $425 million aggregate principal amount of 8.75% senior secured notes due 2031 on September 10, 2026
Notes are guaranteed by certain subsidiaries and secured by first-priority liens on 19 office properties and a pledge of subsidiary guarantor equity
Settlement expected September 24, 2026, subject to customary closing conditions
Proceeds plus cash on hand to repay all borrowings under the secured revolving credit facility and secured term loan
Copart agreed to acquire ACV Auctions through a cash tender offer at $10.50 per share, an implied equity value of about $1.9 billion, followed by a merger. The price is a premium of about 45% to ACV's unaffected closing price on August 10, 2026, and about 41% to its 30-day volume-weighted average price. For Copart shareholders, the company expects the deal to be neutral to earnings per share in the first full year of ownership and accretive in fiscal 2028 and beyond.
Offer price of $10.50 per share in cash, implied equity value of about $1.9 billion
Premium of about 45% to ACV's unaffected closing price on August 10, 2026
Termination fee of $57.7 million payable by ACV; $115.3 million payable by Copart under specified circumstances
Expected to close by calendar year-end 2026, funded with cash on hand; not subject to a financing condition
At its September 4, 2026 annual meeting, SUI Group shareholders re-elected six directors and approved executive compensation, a share issuance for director warrants, and adjournment-related proposal 5 was also approved. The reincorporation from Minnesota to Delaware (Proposal 2) did not receive enough votes, so the meeting was adjourned to October 2, 2026, because approval requires more than 50% of all outstanding shares, not just votes cast.
Six directors were re-elected, including Kristina Campbell (99.66% of votes cast in favor) and Douglas M. Polinsky (99.19%).
Proposal 2 (reincorporation to Delaware) needs more than 50% of outstanding shares as of July 8, 2026; the company says it has more than 33% approval of outstanding shares and over 97% of votes cast so far.
The reconvened meeting is set for October 2, 2026, at 8:30 a.m. Central Time in Wayzata, Minnesota, per the 8-K; the shareholder letter lists 9:30 a.m. Eastern Time.
RUM Group said it expects to acquire additional Northern Data AG shares from Tether Investments on or about September 30, 2026, raising its ownership from 85.2% to approximately 98%. It also notified Northern Data it intends to start squeeze-out proceedings under German law for the remaining roughly 2%, which would bring ownership to 100%.
Ownership in Northern Data expected to rise from 85.2% to approximately 98% on or about September 30, 2026
Shares are acquired from Tether under a Transaction Support Agreement dated November 10, 2025, with exchange for RUM Class A stock at 2.0281 shares per Northern Data share
Squeeze-out proceedings planned for the remaining approximately 2% of Northern Data shares; the price may differ from market price
Filing follows a previously announced $13.7 billion GPU services agreement for the Maysville, GA site
Caring Brands, Inc. appointed Brian R. Meadows as an independent director, effective September 4, 2026. Meadows is president of Myall Luna Ventures Inc., which the company also engaged under a consulting agreement to provide financial and accounting management services for a term running from September 2, 2026 through September 1, 2027. The board considered that consulting relationship when it determined Meadows was independent, which shareholders may weigh when assessing board independence.
Consulting fee of $10,000 per month, payable in advance, with either party able to terminate on at least 30 days' written notice
Director Agreement provides an annual grant of options to purchase 25,000 shares of common stock at market price, expiring five years after issuance
Meadows has served as Chief Financial Officer of Jones Soda Co. since 2025
Board approved the appointment on September 3, 2026, after nominating committee approval on August 28, 2026
iSpecimen received a Nasdaq letter dated September 8, 2026, granting an extension until November 25, 2026 to regain compliance with the minimum stockholders' equity requirement. The company says it plans a best-efforts public offering of approximately $5 million in gross proceeds, but the filing states there is no assurance it will regain or maintain compliance, and shareholders could face delisting if it fails to do so.
Nasdaq first notified the company of noncompliance on May 29, 2026, under Listing Rule 5550(b), which requires at least $2,500,000 in stockholders' equity.
The company cites a private placement that closed May 11, 2026, with gross proceeds of approximately $2.5 million, and a planned public offering of approximately $5 million.
Projections show stockholders' equity of approximately $5.1 million through June 30, 2027, per the filing.
The Deficiency Letter has no immediate effect on trading of the common stock on the Nasdaq Capital Market.
Ameresco's board named two finance vice presidents to serve as interim principal financial officer and interim principal accounting officer while the company searches for a new chief financial officer. CFO Mark Chiplock, who resigned as previously disclosed in an August 19, 2026 filing, leaves the role effective September 25, 2026.
Julie Bradshaw, Vice President, Finance, designated interim principal financial officer on September 8, 2026
Debbie Angelico, Vice President, Finance, designated interim principal accounting officer on September 8, 2026
Mark Chiplock's resignation as CFO and principal financial and accounting officer is effective September 25, 2026
The company has commenced a search for a new Chief Financial Officer
Public Storage agreed on September 9, 2026 to sell C$400 million of senior notes due 2033 through its Canadian finance subsidiary, with the Company and PSOC guaranteeing the notes. The Company expects to use the net proceeds to replenish cash used for the Public Storage Canada acquisition and for other general corporate purposes, and the offering is expected to close on September 16, 2026. This is a debt financing that adds to the Company's borrowings, and the filing does not report any earnings or guidance changes.
Notes: C$400 million aggregate principal, 4.540% annual interest, issued at par, maturing September 16, 2033
Interest paid semi-annually on March 16 and September 16, starting March 16, 2027
Proceeds to replenish cash used for the Public Storage Canada acquisition and for general corporate purposes
Offering expected to close September 16, 2026, subject to customary closing conditions
RH reported second-quarter fiscal 2026 results for the period ended August 1, 2026, with GAAP net revenues of $922.2 million, up 2.6% from a year earlier and above the high end of its guidance. The company also updated its fiscal 2026 outlook, calling for revenue growth of 5.5% to 7.0% and adjusted EBITDA margin of 15.0% to 16.2%, while adjusted EBITDA for the quarter included a $55.1 million tariff benefit.
GAAP net revenues were $922.2 million, up 2.6%; GAAP net income was $60.2 million.
Adjusted EBITDA was $178.5 million (19.4% margin), including a $55.1 million tariff benefit; normalized adjusted EBITDA was $123.5 million (13.4% margin).
Updated fiscal 2026 outlook: revenue growth of 5.5% to 7.0% and adjusted EBITDA margin of 15.0% to 16.2%.
Third-quarter outlook calls for revenue growth of 5.0% to 6.0% and adjusted EBITDA margin of 12.5% to 13.5%.
Champions Oncology reported unaudited first-quarter fiscal 2027 results for the period ended July 31, 2026, with revenue of $15.2 million, up 8.8% from a year earlier. The net loss narrowed to $426,000 from $466,000, and adjusted EBITDA rose to $671,000 from $59,000, though the company still reported a loss and spent more on sales and marketing.
Oncology revenue of $15.2 million, up from $14.0 million in the prior-year quarter
Net loss of $426,000 versus $466,000 a year earlier; basic loss per share of $0.03 in both periods
Adjusted EBITDA of $671,000 versus $59,000; oncology services margin of 51% versus 43%
Sales and marketing expense rose 66.6% to $3.1 million; cash used in operations was $492,000 and cash ended the quarter at $4.4 million with no debt
Kadant's board adopted a succession plan under which Michael C. Colwell becomes president and chief operating officer on October 1, 2026, and president and chief executive officer on January 2, 2027, when Jeffrey L. Powell becomes executive chairman. Chairman Jonathan W. Painter will leave the board on January 2, 2027. The filing contains no financial results, and the changes are a planned leadership transition for shareholders to track.
Michael C. Colwell, 60, is senior vice president responsible for the Industrial Processing segment and will join the board on January 2, 2027.
Jeffrey L. Powell remains president through September 30, 2026, and CEO through January 2, 2027, then becomes executive chairman and retires January 1, 2028.
Powell's annualized base salary will be $998,900 through January 2, 2027, and $499,450 after that, under a Transition and Executive Chairman Agreement.
Jonathan W. Painter, current chairman, will cease to serve as a director on January 2, 2027; he stated his resignation did not result from any disagreement with the Company.
TransMedics appointed Fernando Araujo, most recently CFO of GE HealthCare's Advanced Imaging Solutions segment, as Chief Financial Officer and Treasurer effective September 21, 2026, succeeding Gerardo Hernandez, who will move to a non-executive role and then a senior advisor position focused on Latin America. In the same announcement, the company reiterated its 2026 revenue guidance of $737 million to $757 million, which excludes PAD Aviation and will be revisited with third quarter results. The filing reports no change to financial results or guidance, but the change in finance leadership is a notable item for shareholders.
Fernando Araujo, age 46, becomes CFO and Treasurer effective September 21, 2026, with a $590,000 base salary and a 60% target bonus
Araujo receives a $200,000 cash sign-on bonus plus initial stock option and RSU awards each with a grant date value of approximately $1.75 million
Gerardo Hernandez remains a non-executive employee through December 31, 2026, then serves as a non-employee senior advisor until April 30, 2027
2026 revenue guidance of $737 million to $757 million was reiterated; the company will revisit it with third quarter 2026 results
Dell Technologies and its subsidiaries agreed on September 9, 2026 to sell $5.0 billion of senior notes in four tranches to a group of underwriters. The company says the net proceeds will mainly repay its outstanding 4.900% First Lien Notes due 2026, with any remaining funds used for general corporate purposes, including other debt repayment.
Four tranches total $5.0 billion: $1.25 billion due 2029 at 5.100%, $1.25 billion due 2031 at 5.400%, $1.5 billion due 2033 at 5.600%, and $1.0 billion due 2037 at 5.900%
Public offering prices range from 99.475% to 99.953% of principal amount
Proceeds are expected to repay the 4.900% First Lien Notes due 2026 first, with closing expected on September 15, 2026
Notes are guaranteed on an unsecured basis by Dell Technologies, Denali Intermediate Inc. and Dell Inc.
AIM ImmunoTech Inc. exchanged about $450,000 of a November 18, 2025 promissory note held by Streeterville Capital, LLC for 1,921,441 shares of common stock, at an average conversion price of about $0.234 per share, under agreements dated September 3 and September 4, 2026. Stockholders had approved the conversion at a July 15, 2026 special meeting, and the shares were issued without SEC registration under a Section 3(a)(9) exemption.
Converted about $450,000 of the November 18, 2025 promissory note into 1,921,441 shares
Average conversion price of about $0.234 per share
Agreements signed September 3 and September 4, 2026 with Streeterville Capital, LLC
Stockholders approved the conversion at a special meeting held July 15, 2026
GGeoVax Labs said it has requested a Nasdaq Hearings Panel appeal of a delisting determination it received on August 27, 2026, over the minimum bid price requirement, with a hearing scheduled for October 13, 2026. The company says its stock should keep trading on the Nasdaq Capital Market under GOVX at least through that period, and it reaffirmed its focus on the GEO-MVA vaccine program and Gedeptin.
Nasdaq delisting determination received August 27, 2026, relating to the minimum bid price requirement under Listing Rule 5550(a)(2)
Hearing before the Nasdaq Hearings Panel scheduled for October 13, 2026
Hearing request has stayed any suspension or delisting action; GOVX expected to keep trading at least through that period
GeoVax plans to present a compliance plan to regain and maintain listing standards
CVD Equipment Corporation said its board committed to a restructuring plan that ends new system orders for its CVD equipment business and cuts the workforce by about half, keeping only what is needed for its remaining backlog, warranties, and spare parts, quartz, and services. The company expects a restructuring charge of $0.8 million to $1.0 million in the quarter ending September 30, 2026, and CEO Emmanuel Lakios has left the company and the board, with Vice President of Manufacturing Operations Warren Cheesman named Acting CEO.
Restructuring charge expected at approximately $0.8 million to $1.0 million in the quarter ending September 30, 2026, mainly employee severance
Company will no longer pursue new system orders for its CVD equipment business and will cut its workforce by approximately half
Emmanuel Lakios departed as President and CEO and from the board effective September 3, 2026; Warren Cheesman is Acting CEO
At the end of the second quarter of 2026, the company had $23.5 million in cash and no debt
On September 10, 2026, Williams Companies completed a registered offering of four series of senior unsecured notes, with maturities from 2029 to 2056. The filing discloses the principal amounts, interest rates and redemption terms, and it attaches the supplemental indenture as an exhibit. The filing describes the debt sale without stating how the proceeds will be used.
Four series: $500 million 5.000% notes due 2029, $1.0 billion 5.600% notes due 2033, $750 million 5.800% notes due 2036 and $500 million 6.400% notes due 2056.
Interest is paid semi-annually; the 2029 notes first pay on April 15, 2027, and the other series first pay on March 15, 2027.
The notes were issued under a Form S-3 registration statement and a Fourteenth Supplemental Indenture dated September 10, 2026, with The Bank of New York Mellon Trust Company, N.A. as trustee.
IBEX reported fiscal 2026 results for the year ended June 30, 2026, with full-year revenue up 15.4% to $644.1 million and diluted EPS up 32.8% to $3.13. Fourth-quarter revenue rose 11.6%, but net income fell 8.8% to $8.7 million and diluted EPS fell 11.3% to $0.59. The company also introduced fiscal 2027 guidance and amended its U.S. and UAE credit facilities, extending maturities to October 22, 2029.
Fiscal 2026 revenue $644.1 million, up 15.4%; diluted EPS $3.13 versus $2.36 a year earlier
Fourth-quarter net income $8.7 million versus $9.6 million; net income margin 5.3% versus 6.5%
Fiscal 2027 revenue guidance $700 million to $715 million; adjusted EBITDA guidance $90 million to $94 million
U.S. credit facility of $25 million and UAE facilities amended on September 8, 2026, with maturity extended to October 22, 2029
Oracle reported fiscal first-quarter 2027 results for the quarter ended August 31, 2026, with revenue up 30% to $19.3 billion and diluted GAAP EPS up 55% to $1.56. The company also gave Q2 and full fiscal 2027 guidance, including total revenue of at least $90 billion, and declared dividends. Free cash flow was negative $5.4 billion as capital expenditures reached $28.5 billion, a figure shareholders will watch alongside the growth in cloud revenue.
Total revenue $19.3 billion, up 30%; cloud revenue $11.6 billion, up 62%; cloud infrastructure $7.4 billion, up 121%
Diluted GAAP EPS $1.56, up 55%; non-GAAP EPS $1.92, up 30%
Operating cash flow $23.1 billion, but free cash flow was negative $5.4 billion
Common dividend $0.50 per share payable October 23, 2026 (record date October 9); preferred dividend $1,625 per share payable October 15, 2026
DexCom appointed Glenn S. Boehnlein as a director effective September 10, 2026, increasing the board to thirteen members. He joins the Audit Committee and the Operations & Innovation Committee, and the filing describes him as independent under Nasdaq listing standards.
Boehnlein most recently served as Vice President and Chief Financial Officer of Stryker Corporation from 2016 to 2025.
Initial equity grant of restricted stock units with a fair value of $500,000, vesting annually over three years.
Annual director equity grant expected around the 2027 Annual Meeting with a fair value of $347,500.
Term expires at the 2027 annual meeting of stockholders.
Copart reported fourth-quarter fiscal 2026 results for the three months ended July 31, 2026, with revenue up 2.4% but gross profit down 5.5% and net income attributable to Copart down 17.4%. Diluted earnings per share fell to $0.35 from $0.41, and for the full fiscal year diluted EPS declined to $1.55 from $1.59.
Q4 revenue rose $27.3 million, or 2.4%, to $1.2 billion; gross profit fell $28.3 million, or 5.5%, to $481.4 million
Q4 net income attributable to Copart fell $68.9 million, or 17.4%, to $327.4 million
Fiscal 2026 revenue rose 0.4% to $4.7 billion, while net income attributable to Copart fell 4.4% to $1.5 billion
Fiscal 2026 cash flow statement shows $1.6 billion in common stock repurchases
Energy Transfer LP has approved moving the listings of its common units and Series I Preferred Units from the New York Stock Exchange to the Texas Stock Exchange. The partnership expects NYSE trading to end at market close on October 2, 2026, with TXSE trading beginning at market open on October 5, 2026, and the ticker symbols will remain unchanged.
NYSE trading in the Common Units and Series I Preferred Units expected to end at market close on October 2, 2026
TXSE trading expected to begin at market open on October 5, 2026
Ticker symbols remain unchanged: ET for common units and ETprI for Series I Preferred Units
Board-level approval of the voluntary withdrawal from NYSE dated September 3, 2026
Matador Resources said co-president Van H. Singleton, II retired from his role as Co-President of land, acquisitions and divestitures and planning on September 9, 2026, and moved to a Special Advisor role to the Board and Executive Committee. Bryan A. Erman, already Co-President, Chief Legal Officer and Head of M&A, takes over Singleton's co-presidency, and Jonathan J. Filbert takes over his land and acquisition and divestiture responsibilities.
Van H. Singleton, II retired as Co-President on September 9, 2026 and became Special Advisor to the Board and Executive Committee.
Bryan A. Erman, Co-President since June 2025, assumes Singleton's co-president role.
Jonathan J. Filbert, Executive Vice President – Land since October 2023, takes over land and acquisition and divestiture efforts.
Singleton's advisor agreement provides an annual fee of $450,000 paid monthly and continued vesting of his outstanding equity awards.
Zumiez reported fiscal 2026 second-quarter net sales down 2.5% to $209.0 million, with a net loss of $2.7 million, or $0.17 per share, compared with a net loss of $1.0 million, or $0.06 per share, a year earlier. The company said sales through September 7, 2026 were down 4.3% and gave third-quarter guidance of $222 million to $226 million in net sales and EPS of $0.00 to $0.10, which points to weak results for shareholders.
Q2 net sales were $209.0 million, down 2.5%; comparable sales fell 2.1%.
Q2 net loss was $2.7 million, or $0.17 per share, versus $1.0 million, or $0.06 per share, a year earlier.
Third-quarter guidance (three months ending October 31, 2026): net sales of $222 million to $226 million and EPS of $0.00 to $0.10.
Third quarter-to-date net sales fell 4.3% through September 7, 2026; cash and current marketable securities were $97.3 million, down from $106.7 million a year earlier.
Park Hotels & Resorts approved one-time retention restricted stock awards to four executive officers on September 3, 2026, including 331,564 shares to CEO Thomas J. Baltimore, Jr. The awards vest in full on the fourth anniversary of the grant date, subject to continued employment, and are intended to address leadership transition and recruiting risks. The grants add to the share count tied to executive pay, and their vesting terms determine how much stock is retained if an executive leaves.
September 3, 2026: Compensation & Human Capital Committee approved one-time Retention RSA Awards
Lyell Immunopharma said it completed the technology transfer of LYL273, its GCC-targeted CAR T-cell candidate, to its LyFE facility in Bothell, Washington, after FDA review of an improved manufacturing process. The company also said additional clinical data from the Phase 1/2 trial in metastatic colorectal cancer and an End-of-Phase 1 meeting with the FDA are now expected in 2027, which pushes out the timeline for those milestones.
Technology transfer to the LyFE facility in Bothell, Washington, completed following FDA review of an improved manufacturing process and updated analytical methods
Dosing of additional patients with the new process continues, with the goal of determining the recommended Phase 2 dose and optimized safety management plan
Additional clinical data and the End-of-Phase 1 meeting with the FDA are now expected in 2027
In June 2026, the company reported that gastrointestinal prophylaxis reduced Grade ≥ 2 diarrhea/colitis from 55% without prophylaxis to 10% with prophylaxis
Nasdaq notified Global Interactive Technologies (GITS) on September 10, 2026 that the company is back in compliance with a listing rule after it filed its overdue quarterly report on Form 10-Q for the period ended June 30, 2026. The company had received a notice on August 20, 2026 that it had missed the filing deadline, which could have led to delisting from Nasdaq if not resolved.
Nasdaq notice dated August 20, 2026 cited late filing of the Form 10-Q under Listing Rule 5250(c)(1)
Form 10-Q for the period ended June 30, 2026 was filed on September 9, 2026
Nasdaq confirmed compliance in a notice received September 10, 2026
20/20 Biolabs, Inc. (AIDX) received a Nasdaq notice on September 3, 2026 saying it does not meet the $2,500,000 stockholders' equity requirement, based on its Form 10-Q showing $1,620,700 at June 30, 2026. The company has 45 calendar days to submit a compliance plan, and failing to regain compliance could bar it from the extra time it would otherwise get on the bid price issue, adding delisting risk for shareholders.
September 3, 2026: Nasdaq notice citing stockholders' equity of $1,620,700 versus a $2,500,000 requirement
Company has 45 calendar days to submit a plan to regain compliance; Nasdaq may grant up to 180 more days if accepted
Separate July 17, 2026 notice on the $1.00 bid price rule; compliance deadline is January 13, 2027
Missing the equity rule by January 13, 2027 would disqualify the company from a second bid price compliance period
Frequency Electronics reported first-quarter fiscal 2027 results for the quarter ended July 31, 2026, with revenue of $23.5 million, up from $13.8 million a year earlier. Net income rose to $4.2 million, or $0.41 per diluted share, from $0.07 a year earlier, and the company said a secondary offering added approximately $73 million in cash.
Revenue was approximately $23.5 million, up 70% from $13.8 million in the same quarter of fiscal 2026.
Operating income was $5.2 million, compared with $0.4 million a year earlier.
Net income was $4.2 million, or $0.41 per diluted share, versus $0.07 per diluted share a year earlier.
Funded backlog was approximately $129 million at July 31, 2026, up from $111 million at April 30, 2026.
Autodesk sold $1.0 billion of senior notes in two $500 million tranches, due 2029 and 2033, under an underwriting agreement dated September 8, 2026. The company plans to use the proceeds, along with cash on hand, to repay $1.0 billion of its term loan, so the deal refinances existing borrowing rather than adding a stated new use of funds.
2029 Notes: $500 million at 5.050% interest, paid semi-annually
2033 Notes: $500 million at 5.650% interest, paid semi-annually, first payment March 15, 2027
Proceeds plus cash on hand to repay $1.0 billion under a term loan dated June 15, 2026
Indenture limits liens, sale-leasebacks and certain mergers; a bankruptcy or payment default could trigger acceleration
LightPath Technologies reported results for its fiscal 2026 fourth quarter and full year ended June 30, 2026. Revenue rose 92.7% for the year to $71.7 million and gross profit rose to $25.8 million, but the full-year net loss widened to $20.5 million, mainly due to a $15.6 million non-cash change in the fair value of acquisition earnout liabilities tied to G5 Infrared. For shareholders, the company ended the year with a backlog of approximately $110.9 million and cash of $93.2 million.
Q4 fiscal 2026 revenue was $21.2 million, up 73.8% from $12.2 million; net loss was $4.1 million, or $0.06 per share, versus $7.1 million, or $0.16 per share, a year earlier.
Full-year fiscal 2026 revenue was $71.7 million, up 92.7%; net loss was $20.5 million, or $0.38 per share, versus $14.9 million, or $0.36 per share.
Backlog was approximately $110.9 million at June 30, 2026, up 197% from $37.4 million a year earlier.
Adjusted EBITDA was $2.1 million in Q4 fiscal 2026, compared with a loss of $2.0 million a year earlier; full-year adjusted EBITDA was $4.2 million.
Friedman Industries entered into a Seventh Amendment to its A&R Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent, increasing aggregate commitments from $140 million to $200 million. The company said the expansion aligns its credit facility size with growth in the underlying borrowing base.
Amendment dated September 3, 2026 increases aggregate commitments from $140 million to $200 million
Century Metals & Supplies, LLC, a Texas limited liability company, is also a borrower under the agreement
Original A&R Credit Agreement is dated May 19, 2021; full amendment to be filed with the 10-Q for the quarter ending September 30, 2026
Reformation reported fiscal second-quarter 2026 net revenue of $155.2 million, up 24.1% from a year earlier, and net income of $12.4 million, or $0.23 per diluted share, up 79.4%. The company also set fiscal 2026 net revenue guidance of $602 million to $606 million, but the balance sheet now carries $246.7 million of total debt after term loans funded a dividend of about $90.0 million.
Net revenue rose 24.1% to $155.2 million; DTC revenue grew 21.2% and wholesale grew 48.7%.
Net income was $12.4 million, or $0.23 per diluted share, versus $6.9 million, or $0.13, a year earlier.
Full-year fiscal 2026 outlook: net revenue of $602 million to $606 million and adjusted EBITDA margin of 14% to 14.2%.
On June 17, 2026, the company added $92.0 million of term loans, used to fund an approximately $90.0 million dividend ($1.63 per share); total debt was $246.7 million.
AptarGroup's Chief Accounting Officer, Aditya Gandhi, resigned effective September 11, 2026, to pursue another opportunity outside the greater Chicago area, and the company said the decision was not related to any disagreement on operations, policies or practices. The Board appointed Daniel Ackerman, a former CAO, as interim Chief Accounting Officer and principal accounting officer until a permanent successor is named.
Aditya J. Gandhi resigns as Vice President, Chief Accounting Officer, effective September 11, 2026
Daniel Ackerman, age 53, appointed Senior Vice President, Interim Chief Accounting Officer, effective September 11, 2026
Ackerman previously served as CAO from August 1, 2024 until June 8, 2026, and has been SVP, Finance for Aptar Pharma since June 2026
Ackerman will report to Vanessa Kanu, Executive Vice President and Chief Financial Officer
Adobe reported third quarter fiscal 2026 results for the quarter ended August 28, 2026, with revenue of $6.76 billion, up 13% year over year, and non-GAAP diluted earnings per share of $6.13, up from $5.31 a year earlier. The company also raised its full-year fiscal 2026 revenue and earnings per share targets, which matters to shareholders because it signals higher expected profit for the year.
Q3 FY2026 revenue was $6.76 billion, up 13% year over year (12% in constant currency).
Diluted EPS was $4.62 on a GAAP basis (vs. $4.18) and $6.13 on a non-GAAP basis (vs. $5.31).
FY2026 revenue target is now $26.576 billion to $26.626 billion; non-GAAP EPS target is $24.45 to $24.50.
Q4 FY2026 revenue target is $6.80 billion to $6.85 billion; Q3 share repurchases were about 9.5 million shares.
On September 8, 2026, MYR Group entered a five-year Fourth Amended and Restated Credit Agreement with a bank syndicate led by JPMorgan Chase, Bank of America and Wells Fargo. The deal replaces the company's May 31, 2023 credit agreement, which included a $490 million revolver, and adds a $150 million U.S. dollar term loan and a C$70 million Canadian dollar term loan. Borrowings are secured by substantially all company and domestic subsidiary assets and carry financial covenants, so shareholders should note the added debt capacity and its collateral and leverage conditions.
Agreement dated September 8, 2026, is a five-year Fourth Amended and Restated Credit Agreement led by JPMorgan Chase Bank, N.A., Bank of America, N.A. and Wells Fargo Bank, National Association.
Revolving facility of $690 million, plus a $150 million U.S. dollar term loan and a C$70 million Canadian dollar term loan.
Expansion option allows up to an additional $445 million of commitments or incremental term loans, subject to conditions; prior agreement had a $490 million revolver and a $200 million expansion option.
Financial covenants include a maximum Net Leverage Ratio of 3.0 and a minimum interest coverage ratio of 3.0; borrowings are secured by substantially all assets of the company and its domestic subsidiaries.
DigitalOcean and its subsidiary entered into a $725 million equipment finance facility with MUFG entities to fund data center equipment, with an accordion feature that could raise total commitments to $1.025 billion. The company says it intends to exercise the accordion in full, subject to new or existing lenders committing, and the facility is guaranteed by the parent and certain subsidiaries and secured by the equipment. The new debt-like obligation carries fixed rates tied to term SOFR swaps plus 2.75% and financial covenants, and the CFO said the company remains highly confident in its 2026 guidance.
Committed financing of up to $725 million; advances can fund up to 90% of equipment cost, with the balance paid as prepaid rent
Accordion can add up to $300 million, for up to $1.025 billion in total, subject to lender commitments
Advances available until September 10, 2027; rent amortizes each advance in full by September 10, 2030
Each advance bears a fixed rate equal to term SOFR swap rate plus 2.75%; undrawn commitment fee of 0.20% rising to 0.40% six months after closing
Tarsus Pharmaceuticals completed its acquisition of Alkeus Pharmaceuticals on September 4, 2026, paying $270 million in cash and issuing 2,908,692 shares at closing. Alkeus shareholders may also receive up to $350 million in milestone payments tied to regulatory approval and first U.S. sales, plus revenue-sharing payments on future gildeuretinol sales. The filing does not provide financial results for Alkeus, so its effect on Tarsus's financials is not yet quantified.
Acquisition closed September 4, 2026, with Alkeus becoming a wholly-owned subsidiary of Tarsus
Up-front consideration: $270,000,000 in cash, subject to adjustments, plus 2,908,692 shares of common stock
Milestones up to $350 million: $250 million on U.S. regulatory approval of an Alkeus product, and $100 million in cash on first U.S. sale
Financial statements and pro forma information will be filed by amendment within 71 calendar days
Insulet directors Timothy J. Scannell and Michael R. Minogue are stepping down from the board, effective September 3 and September 15, 2026, respectively. Scannell cited health reasons, and Minogue is leaving to focus on his candidacy for Governor of Massachusetts; the filing says neither departure stems from a disagreement with the company.
Timothy J. Scannell, who served 12 years on the board including 7 years as Chairman, steps down effective September 3, 2026, citing health reasons
Michael R. Minogue, who served 9 years, notified the company on September 8, 2026 and steps down effective September 15, 2026 to pursue a run for Governor of Massachusetts
The filing states neither director resigned due to a disagreement with the company on operations, policies or practices
Unity Bancorp purchased about $27.6 million of transferable federal investment tax credits for about $25.1 million on September 10, 2026. The company expects a one-time reduction in income tax expense of about $2.5 million, which would increase net income, in the quarter ending September 30, 2026.
Credits purchased for about $25.1 million, about $0.91 per dollar of tax credit
Expected one-time income tax expense reduction and net income increase of about $2.5 million in the quarter ending September 30, 2026
Company plans to use the credits mainly through a carry-back claim; credits remain subject to a five-year recapture period
Three Lions Acquisition Corp., a blank-check company, filed an audited September 2, 2026 balance sheet reflecting the closing of its initial public offering of 10,000,000 units at $10.00 per unit. The company placed $100,500,000 in a trust account for public shareholders, and the balance sheet shows $1,236,590 in cash outside the trust.
IPO of 10,000,000 units at $10.00 per unit closed September 2, 2026, generating $100,000,000 in gross proceeds
Private placement of 400,000 units at $10.00 per unit generated $4,000,000 in gross proceeds
$100,500,000 ($10.05 per unit) was deposited in the trust account; the company has 21 months from the IPO closing to complete a business combination
Central Plains Bancshares, Inc. said its Board of Directors approved a new stock repurchase program on September 9, 2026, under which it may buy back up to 417,481 shares, approximately 10% of current outstanding shares. The new program replaces the company's current repurchase program. The filing does not state a timing or funding for repurchases.
Board approved the new repurchase program on September 9, 2026
Program covers up to 417,481 shares, approximately 10% of current outstanding shares
New program replaces the company's current repurchase program
Announced in press release dated September 9, 2026 (Exhibit 99.1)
MercadoLibre agreed on September 9, 2026 to sell $1 billion of 5.850% Notes due 2036 to a group of underwriters under an SEC-registered shelf. The company said proceeds will be used for general corporate purposes and to strengthen its liquidity, and the notes are guaranteed by several of its subsidiaries.
Size: $1,000 million aggregate principal amount of 5.850% Notes due 2036, a 10-year tenor
Underwriting agreement dated September 9, 2026 with BofA Securities, Citigroup, Goldman Sachs, J.P. Morgan and Morgan Stanley as representatives
Issuer ratings cited in the press release: BBB- (S&P), Baa3 (Moody's), BBB- (Fitch)
The press release says the deal drew demand from more than one hundred institutional investors
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.